Pharmaron Beijing Co., Ltd.

SZSE:300759 Stock Report

Market Cap: CN¥35.0b

Pharmaron Beijing Future Growth

Future criteria checks 1/6

Pharmaron Beijing is forecast to grow earnings and revenue by 15.5% and 13% per annum respectively. EPS is expected to grow by 15.3% per annum. Return on equity is forecast to be 13.1% in 3 years.

Key information

15.5%

Earnings growth rate

15.3%

EPS growth rate

Life Sciences earnings growth27.6%
Revenue growth rate13.0%
Future return on equity13.1%
Analyst coverage

Good

Last updated05 Aug 2024

Recent future growth updates

Recent updates

Pharmaron Beijing Co., Ltd.'s (SZSE:300759) Intrinsic Value Is Potentially 69% Above Its Share Price

May 12
Pharmaron Beijing Co., Ltd.'s (SZSE:300759) Intrinsic Value Is Potentially 69% Above Its Share Price

Pharmaron Beijing Co., Ltd.'s (SZSE:300759) 27% Share Price Surge Not Quite Adding Up

Mar 04
Pharmaron Beijing Co., Ltd.'s (SZSE:300759) 27% Share Price Surge Not Quite Adding Up

Pharmaron Beijing (SZSE:300759) Seems To Use Debt Quite Sensibly

Feb 27
Pharmaron Beijing (SZSE:300759) Seems To Use Debt Quite Sensibly

Earnings and Revenue Growth Forecasts

SZSE:300759 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202616,4332,2641,2913,18214
12/31/202514,4642,0375162,87116
12/31/202412,7371,706-952,40414
3/31/202411,4851,4833902,969N/A
12/31/202311,5381,601-1122,754N/A
9/30/202311,4241,553-2142,777N/A
6/30/202311,2721,575-5722,564N/A
3/31/202310,8871,474-8062,255N/A
1/1/202310,2661,375-8072,143N/A
9/30/20229,5451,582-7072,037N/A
6/30/20228,7931,682-3002,072N/A
3/31/20228,0571,664-2421,977N/A
12/31/20217,4441,661-352,058N/A
9/30/20216,8491,423-1521,905N/A
6/30/20216,2261,258-791,876N/A
3/31/20215,6641,3171251,822N/A
12/31/20205,1341,1723331,649N/A
9/30/20204,7171,0085321,565N/A
6/30/20204,3148654401,283N/A
3/31/20203,9535943701,124N/A
12/31/20193,757547184939N/A
9/30/20193,499437146837N/A
6/30/20193,274378247906N/A
3/31/20193,089346230861N/A
12/31/20182,908333150791N/A
9/30/20182,713300-721692N/A
12/31/20172,294231N/A552N/A
12/31/20161,634177N/A236N/A
12/31/20151,12874N/A217N/A
12/31/201479021N/A12N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300759's forecast earnings growth (15.5% per year) is above the savings rate (2.9%).

Earnings vs Market: 300759's earnings (15.5% per year) are forecast to grow slower than the CN market (22% per year).

High Growth Earnings: 300759's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300759's revenue (13% per year) is forecast to grow slower than the CN market (13.5% per year).

High Growth Revenue: 300759's revenue (13% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300759's Return on Equity is forecast to be low in 3 years time (13.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.